Dual-action acidic PLGA nanoparticles delivering ivacaftor directly into RPE lysosomes combine physicochemical proton...
IF dual-action acidic PLGA nanoparticles (~100–150 nm, formulated at pH 4.5–5.0 core with surface-conjugated ivacaftor, a clinically approved CFTR channel potentiator) are administered via a single intravitreal injection (dose range: 1–5 µg ivacaftor equivalent per eye) to aged (12–18 month) male and female ABCA4−/− mice with chronically elevated lysosomal A2E burden,
THEN a ≥40% reduction in RPE A2E/lipofuscin autofluorescence intensity (measured by fundus autofluorescence imaging and HPLC-quantified A2E extraction), accompanied by restoration of lysosomal pH to ≤5.0 (LysoSensor ratiometric imaging), measurable within 4–8 weeks post-injection, will be observed,
BECAUSE the following step-by-step causal chain is operative:
-
Nanoparticle uptake by RPE: PLGA nanoparticles in the 50–200 nm range are internalized by RPE cells via phagocytic and endocytic pathways following intravitreal injection, trafficked to lysosomes where the acidic nanoparticle core directly donates protons upon degradation, providing an immediate physicochemical re-acidification impulse. (Lysosomal re-acidification by acidic nanoparticles lowers lysosomal pH and improves outer segment degradation)[https://doi.org/10.1007/978-1-4614-3209-8_14]
-
PLGA-mediated sustained acid release: As the PLGA matrix hydrolyzes, it releases lactic and glycolic acid, sustaining intra-lysosomal acidification over days to weeks — a cross-discipline materials science mechanism (polymer acid degradation byproducts) repurposed as a biological repair tool. [SPECULATIVE: sustained acid release magnitude within lysosomes not yet quantified for PLGA in RPE context]
-
Ivacaftor-mediated CFTR potentiation: Concurrently, ivacaftor released from the nanoparticle core potentiates CFTR channel opening in the lysosomal/endosomal membrane, increasing Cl⁻ conductance. CFTR activation independently re-acidifies lysosomes and restores outer segment degradation in compromised RPE cells, acting through a receptor-mediated pathway distinct from the physicochemical acid donation. (CFTR channel activation reacidifies lysosomes and increases degradation of photoreceptor outer segments)[https://doi.org/10.1007/978-1-4614-3209-8_14]
-
Synergistic dual-mechanism re-acidification: The two mechanisms — direct physicochemical proton donation and sustained CFTR-gated Cl⁻/H⁺ co-transport — converge on restoring V-ATPase-driven proton gradient integrity, achieving lysosomal pH restoration that neither mechanism alone is likely to sustain in the face of chronically elevated A2E. [SPECULATIVE: synergistic magnitude unquantified; based on additive logic from independent mechanism evidence]
-
Lysosomal enzyme reactivation: Restoration of pH to ≤5.0 reactivates cathepsins D, B, and L, which function optimally in an acidic range and are impaired by A2E-mediated alkalinization. Functional degradative enzyme activity then processes the accumulated A2E and bisretinoid photoproducts — constituting active RE...
SENS category: LysoSENS
Key references: • doi.org/10.1007/978-1-4614-3209-8_14 • doi.org/10.1126/science.aag3048 • doi.org/10.1007/978-1-4614-3209-8_14] • doi.org/10.1126/science.aag3048] • doi.org/10.1101/2025.01.14.632938]